ArticleBiomedicines2023

Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer.

Eman A Toraih et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.